<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00795314</url>
  </required_header>
  <id_info>
    <org_study_id>NMU-2008-FY10MZ31</org_study_id>
    <secondary_id>NJFY0811-MZ02</secondary_id>
    <nct_id>NCT00795314</nct_id>
  </id_info>
  <brief_title>Propofol-butorphanol Anesthesia During Uterine Curettage</brief_title>
  <acronym>PABADUC</acronym>
  <official_title>Propofol-butorphanol Combined Anesthesia During Uterine Curettage on Abortion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Uterine curettage is usually performed under the anesthesia of propofol-fentanyl or
      para-cervical block,of which generally has significant incidence of respiratory depression
      which increases the demand on intraoperative monitoring, or has unavoidable insufficient
      blockade which results in intraoperative suffering of pain. Butorphanol is an analgesic with
      combined effects on mu and kappa opioid receptors leading to a role as analgesia and
      sedation. The investigators hypothesized that combined propofol with butorphanol during
      uterine curettage would produce optimal effectiveness of these two drugs by adding sedative
      and analgesic effects together. In addition, it would decrease the intraoperative consumption
      of propofol without increase the incidence of side effects. Furthermore, such combination
      would alleviate postoperative pain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative awareness</measure>
    <time_frame>During the whole process of anesthesia</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bispectral Index (BIS) value</measure>
    <time_frame>During the whole process of anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anesthetic consumptions</measure>
    <time_frame>From the start of operation to the end of surgical procedures</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Since the end of the operation to 48 h follow-up.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative bleeding</measure>
    <time_frame>Since the end of operation to 48 h follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Abortion</condition>
  <condition>Curettage</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol-fentanyl combined anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol-butorphanol combined anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl Citrate</intervention_name>
    <description>Combined anesthesia with propofol (2-2.5mg/kg) and fentanyl (5 μg)</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Actiq®</other_name>
    <other_name>Fentora TM</other_name>
    <other_name>Duragesic®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Butorphanol Tartrate</intervention_name>
    <description>Combined anesthesia with propofol (2-2.5 mg/kg) and butorphanol (1mg)</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Torbugesic®</other_name>
    <other_name>Torbutrol®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA status I-II;

          -  Performing abortion operation (medical- or drug-induced);

          -  Requiring painless abortion;

        Exclusion Criteria:

          -  &lt; 19yrs, and &gt;= 45yrs;

          -  History of central active drugs administration;

          -  Drug abuse;

          -  Hypertension;

          -  Diabetes;

          -  Any other chronic diseases;

          -  Allergy to the study drugs;

          -  Habit of over-volume alcohol drinking;

          -  Records of history of centrally active drug use and psychiatry;

          -  Any organic disorders.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XiaoFeng Shen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nanjing Maternal and Child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2008</study_first_submitted>
  <study_first_submitted_qc>November 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2008</study_first_posted>
  <last_update_submitted>July 14, 2009</last_update_submitted>
  <last_update_submitted_qc>July 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>XiaoFeng Shen</name_title>
    <organization>Nanjing Medical University</organization>
  </responsible_party>
  <keyword>Opioids</keyword>
  <keyword>General anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Butorphanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

